Markets Stocks Economy Crypto Earnings Banking Energy
Home Stocks Feature
Stocks · Exclusive

H.B. Fuller rejects Ancora's $1.2 billion bid for building adhesives unit

H.B. Fuller rejects Ancora's $1.2 billion bid for building adhesives unit
Stocks · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Aug 24, 2026 4 min read

H.B. Fuller, the adhesives maker, has formally rejected an unsolicited $1.2 billion cash offer from activist investor Ancora for its Building Adhesives Solutions (BAS) unit. The company's board said the bid "undervalues" the business and warned that separating it would create operational inefficiencies because the unit shares manufacturing with other parts of the company.

The decision, announced on Monday, marks the latest clash between a company and an activist investor pushing for a breakup. Ancora had proposed to buy BAS outright, a move that would have given the activist a direct stake in a business it believes is underperforming within H.B. Fuller's broader portfolio.

Why the board said no

In its statement, H.B. Fuller said the offer did not reflect the true value of BAS, which makes adhesives used in construction, roofing, and other building applications. The company also stressed that BAS shares manufacturing facilities and supply chains with other divisions, meaning a carve-out would likely raise costs and disrupt operations rather than unlock value.

"The board's decision was unanimous and based on a thorough review of the proposal," the company said. "We believe the BAS business is strategically important and better positioned to create value as part of H.B. Fuller."

This is a common argument from companies resisting activist demands. When a business unit shares factories, logistics, or sales teams with other parts of the company, separating it can be expensive and time-consuming. The synergies that exist today—shared overhead, bulk purchasing, and integrated production—can be lost, potentially wiping out the very value the buyer hopes to capture.

What is H.B. Fuller?

H.B. Fuller is a global specialty chemicals company that produces adhesives, sealants, and other specialty products. Its customers range from construction firms to packaging companies. The BAS unit specifically serves the building and construction sector, providing products like roofing adhesives and insulation fasteners.

The company has been under pressure from Ancora, which has been pushing for changes to improve shareholder returns. Activist investors often target companies they believe are undervalued or have underperforming divisions that could be sold or spun off to unlock value.

In this case, Ancora's offer was for the BAS unit alone, not the entire company. That kind of targeted bid is unusual but not unheard of. It reflects a belief that the unit is worth more on its own than as part of H.B. Fuller.

What it means for investors

For everyday investors, this news is a reminder that activist campaigns can create uncertainty—and sometimes opportunity. When a company rejects a bid, the stock can move in either direction. If investors believe the offer was too low, the stock might rise on hopes of a higher bid or a better strategic plan. If they think the company is being stubborn, the stock could fall.

H.B. Fuller's rejection suggests management is confident it can create more value by keeping BAS. But that confidence will be tested. The company will need to show that it can grow the unit and improve overall profitability. If it fails, shareholders may pressure the board to reconsider.

For those who own H.B. Fuller stock, the key question is whether the company's long-term strategy will deliver better returns than a quick sale. For those considering buying, the situation highlights the risks of investing in companies with activist involvement—there's no guarantee the activist's plan will succeed, and the process can be distracting for management.

It's also worth noting that this is not a done deal. Ancora could raise its bid, or other buyers could emerge. But for now, the board has drawn a line in the sand.

In the broader context of M&A activity, this rejection is a reminder that not all offers are welcome. Companies have the right to refuse bids they believe are inadequate, and they often do so when they think the long-term value is higher. Investors should watch for any further developments, including whether Ancora escalates its campaign or walks away.

For more on how activist investors and M&A deals can move markets, see our coverage of KKR's acquisition of Australia's Steadfast and MPS's twin all-share offers in Italian banking.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B